🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌎 Oncólogos de LATAM 🌎 ¡Ayúdanos a mejorar las emergencias oncológicas! Participa en esta encuesta internacional (⏱️<10 min, anónima y confidencial). 📩 forms.gle/uLpvsz5WvXUhma… DM si tienes dudas. ¡Gracias por difundir! #Oncología #LATAM #SaludGlobal

So far, every single abstract I’ve listened to at #EHA25 reporting a clinical trial has claimed the study drug was “well tolerated” - despite patients discontinuing therapy due to AEs. One speaker said “well tolerated” >10 times. It’s meaningless. Let data speak for itself.

NEW FDA- Make Surrogate Endpoints Great Again! 100% of cancer drug approvals since May 2025 have been on the basis of surrogate endpoints. The latest approval in fact celebrates “no detriment” in OS. 🤦‍♂️

Oh The Lancet, when will you finally let go of this bad habit? If the side effects are “manageable,” then why were there 12 treatment-related Grade 5 toxicities?! Terminology must be used accurately and responsibly!

Las claves de los «detectives» del cáncer hereditario: «Saber que tienes una mutación puede salvarte la vida» 📰 La Voz de la Salud analiza, con la participación de la Dra. Sánchez Heras, los tumores hereditarios más frecuentes y las medidas de prevención lavozdegalicia.es/noticia/lavozd…

Nice move, but reviewing = mostly thankless job that can take a lot of time & effort…& now potentially more if one knows their reviews will be published. Another reason reviewers should be paid! (recall Nature charges > $12K for open access)

Sergio Cifuentes Promotes International Acute Oncology Services Survey for Latin American Oncologists Sergio Cifuentes oncodaily.com/blog/sergio-ci… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews

What’s the point in journals “offering transfer service” when the transferred journal makes you do the whole process again?

🎙️Open Doors, Drs. Ioanna and Vilma #podcast Sergio Cifuentes and Teresa Amaral, MD, PhD thank you for such an inspiring conversation. Thank you OncoDaily for your support and feedback. 🌟Grateful to all our guests and listeners, keep opening doors for yourself and others. #Resilience

I think this is also true about medicine and surgery… instagram.com/reel/DHbXYbkpG…

Not surprisingly another NEJM article over emphasizing the role of drugs and underemphasizing secular trends in decreased smoking, LDCT screening, earlier detection, better local tx (including SBRT), MDT…

🎙️ I had the honor to join the #OpenDoorsPodcast hosted by Drs. Ioanna Nixon & Vilma Pacheco to share my journey in oncology from LATAM 🌎 We talked about challenges, #resilience, and the power of global #mentorship #ASCOIDEA #Wellbeing ⁦OncoDaily⁩ linkedin.com/posts/open-doo…

This important information for my fellow colleagues from LATAM interested in GI Oncology. Asociación Colombiana de Hematología y Oncología OncoDaily Dr Amol Akhade

Oncología y sufrimiento: estrategias para afrontar el duelo en profesionales de la salud. Publicado por ASCO …independientedeoncologia.blogspot.com/2025/07/oncolo…

No se pierdan este episodio de Código Tumoral en donde platicamos acerca del sentido común en oncología y de las iniciativas de Common Sense Oncology. ¡Gracias por la invitación!

Recepción en la Embajada de EE.UU, junto a los becarios españoles del programa Fulbright. Ana Albaladejo González, investigadora predoctoral de nuestro grupo del @Area2Cartagena, UCAM Universidad, Instituto Murciano de Investigación Biosanitaria realizará su estancia predoctoral de 6 meses en el laboratorio del Dr. Jorge

Very interesting readers' comments on this piece. Do board exams make us better doctors? medscape.com/viewarticle/do…

Desde mi consulta: Mujer, 74 años. Vida dura. Le diagnosticaron cáncer de pulmón avanzado hace 8 a. Con cada uno de sus 6 nietos, que ha visto crecer, se tatuó una inicial. Ahora está llegando ya al final. Y se ha tatuado está mariposa. Me ha dicho que es para echar a volar ❤️

Proud to co-author this review applying Alma Ata (1978) principles to #Oncology: equity, universal access, community participation & addressing social determinants through primary health care-core to rethinking cancer care Common Sense Oncology Thanks Javier David Benitez Fuentes journals.sagepub.com/doi/10.1177/10…

Cerebrospinal Fluid Liquid Biopsy for Glioma Shows Clinical Management Potential medpagetoday.com/hematologyonco… SEOM GEINO ESMO - Eur. Oncology Annals of Oncology